Argentina Holds 14th National Cannabis March To Protest Criminalization

Regulations by 2FIRSTS.ai
Nov.17.2023
Argentina Holds 14th National Cannabis March To Protest Criminalization
Argentina holds its 14th National Cannabis March, advocating for the decriminalization of marijuana and highlighting its various uses.

According to a report by Pagina12, Argentina held the 14th National Marijuana March, where various social organizations, citizen groups, marijuana cultivators, and users joined forces to raise awareness about the diverse uses of marijuana. They also protested against the criminalization of marijuana by the judicial and police system. The main slogan of the protest was "Stop incriminating based on marijuana.

 

They believe that despite the progress made by laws such as the Medical Marijuana Act No. 27.350 and the Medical and Industrial Cannabis Production Act No. 27.669, these regulations have yet to reflect the actual situation of cannabis culture still being criminalized.

 

A nationwide protest is taking place amidst the growth of the marijuana industry, advocating for an end to the incarceration of marijuana cultivators.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

2Firsts Interview | Duties, Due Diligence and Dialogue:  Tobacco Europe’s Nathalie Darge Evaluates the EU Nicotine Sector’s Greatest Challenges
2Firsts Interview | Duties, Due Diligence and Dialogue: Tobacco Europe’s Nathalie Darge Evaluates the EU Nicotine Sector’s Greatest Challenges
Aug.11
NJOY Sues FDA Over Delayed Ruling on Flavored Disposable Vapes
NJOY Sues FDA Over Delayed Ruling on Flavored Disposable Vapes
Altria’s subsidiary NJOY has sued the U.S. Food and Drug Administration (FDA) and the U.S. Department of Health and Human Services (HHS), alleging prolonged delays in ruling on its appeal for flavored disposable vapes. NJOY argues the products are identical to authorized versions and backed by scientific data and safeguards, yet the review has taken far beyond statutory limits, blocking lawful products while illicit ones flood the market.
Aug.24
BAT's H1 2025 Financial Report: Vuse Sales Down Nearly 13%, Velo Revenue up Over 40%
BAT's H1 2025 Financial Report: Vuse Sales Down Nearly 13%, Velo Revenue up Over 40%
BAT reported H1 2025 revenue of £12.07 billion, down 2.2% due to FX, but up 1.8% at constant rates. Smoke-free products made up 18.2% of total revenue, with Velo sales rising 40.6%. BAT maintained its full-year outlook and raised its 2025 share buyback to £1.1 billion.
Jul.31 by 2FIRSTS.ai
UK Disposable Vape Ban Circumvented: Imitation Reusable Devices Sell 5.3 Million Units in a Month, While Pods Reach Only 1.4 Million
UK Disposable Vape Ban Circumvented: Imitation Reusable Devices Sell 5.3 Million Units in a Month, While Pods Reach Only 1.4 Million
The UK’s disposable vape ban, which came into effect on June 1, has proven ineffective. Disposable vapes were banned due to concerns over youth uptake and waste, but manufacturers have launched imitation reusable products that are nearly identical in name, flavor, and appearance. Industry data and surveys show that 5.3 million imitation devices were sold in the first month of the ban, compared to just 1.4 million pods. On average, users purchase a new device every 16 days instead of buying pods,
Aug.19 by 2FIRSTS.ai
Customs Officers Seize Large Shipment of Illegal Chinese Vapes in Sofia, Bulgaria
Customs Officers Seize Large Shipment of Illegal Chinese Vapes in Sofia, Bulgaria
Authorities in Sofia have seized 2,800 illegal disposable vapes, each containing 15ml of liquid—a total of 42,000ml—during an inspection at a logistics warehouse. The products, imported from China and disguised as waterproof sprays, far exceeded legal limits under Bulgarian law.
Aug.22 by 2FIRSTS.ai
Experts Make the Case for THR in Asia-Pacific, as Demand, Science, and Industry Drive Its Growth
Experts Make the Case for THR in Asia-Pacific, as Demand, Science, and Industry Drive Its Growth
At the inaugural AFN, Dr. Rohan Sequeira and Dr. Alex Wodak emphasized that THR offers a science-based approach to reduce smoking-related harm—not merely as an alternative to cessation. They urged policymakers across Asia to reassess tobacco control and include non-combustible products in public health strategies. This article outlines the scientific foundation of THR, its regional challenges, and growth momentum.2Firsts provided in-depth coverage of the forum.
Sep.09